Skip to content

Multicenter Study on Early Arterial Changes in Prediabetic Patients Evaluated by Ultra-High-Frequency Ultrasound

Multicenter Study on Early Arterial Changes in Prediabetic Patients Evaluated by Ultra-High-Frequency Ultrasound

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111287
Enrollment
Unknown
Registered
2025-10-29
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prediabetes

Interventions

Prediabetic patient group:None
Healthy control group:None

Sponsors

The First Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Meeting the 2019 WHO diagnostic criteria for prediabetes: impaired fasting glucose (venous plasma glucose =6.1 mmol/L, <7.0 mmol/L, and post-load glucose <7.8 mmol/L) and/or impaired glucose tolerance (venous plasma glucose <7.0 mmol/L, post-load glucose =7.8 mmol/L, <11.1 mmol/L). 2. Age 18–79 years. 3. Normal blood pressure (139–90/89–60 mmHg). 4. Body mass index BMI <30 kg/m². 5. Normal results in blood tests, lipid profile, liver and kidney function tests, and electrocardiogram. 6. No history of cardiovascular disease, rheumatic connective tissue disease, or severe liver/kidney dysfunction. 7. No history of acrocyanosis, no discomfort upon cold stimulation, and no occurrence of Raynaud’s phenomenon in any part of the body. 8. No history of taking medications that affect the cardiovascular system.

Exclusion criteria

Exclusion criteria: 1. Suffering from hypertension, hyperthyroidism, arrhythmia, and other diseases. 2. Suffering from connective tissue diseases such as systemic lupus erythematosus, polymyositis, rheumatoid arthritis. 3. Having a history of blood diseases, severe infections, or other systemic diseases. 4. Having taken vasoconstrictor or vasodilator drugs within the past month. 5. Peripheral vascular disease with arterial occlusion and undetectable blood flow signals. 6. Unable to cooperate with the examination.

Design outcomes

Primary

MeasureTime frame
Arterial internal diameter;Arterial intima;Arterial media;

Secondary

MeasureTime frame
Peak Systolic Velocity;End-Diastolic Velocity;Pulsatility Index;Resistive Index;Systolic/Diastolic Ratio;Minimum Velocity;Peak Mean Velocity;Mean Velocity;

Countries

China

Contacts

Public ContactChunyan Ma

The First Hospital of China Medical University

cmu1h_mcy@126.com+86 139 9881 6448

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026